Inulin-type Fructans-rich Vegetables, Obesity, Gut Microbiota
- Conditions
- Obesity
- Interventions
- Dietary Supplement: PlaceboDietary Supplement: Inulin
- Registration Number
- NCT03852069
- Lead Sponsor
- Cliniques universitaires Saint-Luc- Université Catholique de Louvain
- Brief Summary
The purpose of the study was to evaluate the effect of a diet based on ITF-rich vegetables in combination with purified ITF supplementation on weight management, metabolic alteration and gut microbiota composition. Obese patients were treated for 3 months and several parameters were measured before and after the study period.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 106
- Body mass index > 30 kg/m²
- Caucasian
- Presence of at least one of the following comorbidity : prediabetes, diabetes, dyslipidemia, hypertension, steatosis.
- Psychiatric problems or use of antipsychotic
- Consumption of antibiotics, pro/prebiotics, fibre dietary supplement, or any molecules that modifies the intestinal transit (<6 weeks)
- Pregnancy in progress or planified within 6 months
- Specific dietary practise (vegetarian, vegan,...)
- Specific dietary treatment (<6 weeks) (e.g. high protein diet)
- Type 1 diabetes
- Excessive alcohol consumption (>3 glasses/day)
- Inconclusive acceptability test (regarding the protocol of the intervention and the vegetables used in the protocol)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Placebo Placebo 16 g maltodextrin/day + recipes based on vegetables poor in inulin-type fructans Inulin Inulin 16 g inulin/day + recipes based on vegetables rich in inulin-type fructans
- Primary Outcome Measures
Name Time Method Gut microbiota composition Month 0 - Month 3 Relative abundance (percent) of bacterial taxa will be assessed by 16S rRNA gene sequencing
- Secondary Outcome Measures
Name Time Method Mood and emotional competence Month 0 - Month 3 Profile of Emotional Competence (PEC, from 0 to 5, higher score associated with better emotional competence).
Dietary intake Month 0 - Month 3 one-week recall questionnaire to evaluate the dietary intake (macronutrients, caloric intake)
Hepatic fibrosis and/or steatosis Month 0 - Month 3 controlled attenuation parameter (CAP) by Fibroscan (dB/m)
Cognition Month 0 - Month 3 computer-based tests of the flexibility, the working memory and the inhibition of participants. The measurements will be the time to complete the task on the computer as well as the number of errors.
Metabolomics Month 0 - Month 3 metabolomic analysis of biological samples (urine, blood and/or stool)
Physical activity Month 0 - Month 3 IPAQ questionnaire (The IPAQ long form asks details about the specific types of activities undertaken within the four main domains (leisure time PA, domestic and gardening (yard) activities, work-related PA and transport-related PA). Computation of the total scores for the long form requires summation of the duration (in minutes) and frequency (days) for all the types of activities in all domains. Results allowed us to classify different levels of PA proposed by the questionnaire (total, low-moderate or high-intensity physical activities)
Blood pressure Month 0 - Month 3 systolic and diastolic blood pressures (mm Hg)
Glucose homeostasis Month 0 - Month 3 dipeptidyl-peptidase IV activity in the plasma (UI/l)
Lipid homeostasis Month 0 - Month 3 HLD-Cholesterol, triglycerides, total cholesterol, free fatty acids in the plasma (mg/dl)
Eating behavior Month 0 - Month 3 Dutch Eating Behaviour Questionnaire (DEBQ).The DEBQ is a 33-items questionnaire assessing 3 distinct behaviour: emotional eating (13 items), external eating (10 items) and restrained eating (10 items). Each item is rated on a 5-point scale. A high score is observed when individual tended to eat more when submitted to emotional and external stimuli (for emotional and external eating subscales) or when he displayed elevated cognitive control on its eating behaviour (for the restrained eating subscale).
Gut peptides Month 0 - Month 3 Gut peptide (GLP-1, GIP, ghrelin, PP, leptin) multiplex immunoassay (all in pg/ml)
Anthropometry Month 0 - Month 3 Body composition by CT scan analysis (fat and muscle areas, cm2)
Biomarkers of systemic inflammation Month 0 - Month 3 Cytokines levels (Il-1β; IL-8; IL-12p70; IL-17a; MCP1; TNFα; IFNγ) by multiplex immunoassay (all in pg/ml)